Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07065136 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of 627 in Healthy Adult Subjects

Name: Evaluation of 627 in Healthy Adult Subjects — clinical trial record (NCT07065136)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorSunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Started2025-07-20

View on ClinicalTrials.gov ↗

Record status

This record was last updated July 15, 2025 (before its estimated September 18, 2026 completion). Its status may not reflect the trial's current state.

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

22 trials monitored

See all monitored trials

This is a randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose phase I clinical study to evaluate the safety, tolerability, PK and immunogenicity of SSGJ-627 in healthy adult subjects after single subcutaneous injection.

Trial Details

NCT Number	NCT07065136
Lead Sponsor	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Conditions	Healthy Subjects (HS)
Enrollment	108 participants
Start Date	2025-07-20
Primary Completion	2026-09-18 (estimated)
Study Completion	2026-09-18 (estimated)
Updated on ClinicalTrials.gov	2025-07-15